N
Nexalin Technology D
D
NXL
1.28000
USD
-0.20
(-13.51%)
مغلق
حجم التداول
66,127
الربح لكل سهم
0
العائد الربحي
-
P/E
-2
حجم السوق
22,294,949
العنوان: Nexalin Technology
القطاع: Healthcare
الصناعة: Medical Devices
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 orGen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.